Polly A Niravath (Polly Niravath)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Nitric Oxide Synthase

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Sun, Yitian Xu, Licheng Zhang, Polly A Niravath, Jorge G Darcourt, Tejal Patel, Bin S Teh, Andrew M Farach, Carlo Guerrero, Sunil Mathur, Mark A Sultenfuss, Nakul Gupta, Mary R Schwartz, Susan L Haley, Sindhu Nair, Xiaoxian Li, Thi Truc Anh Nguyen, Joseph D Butner, Joe E Ensor, Jaime A Mejia, Zhuyong Mei, E Brian Butler, Shu-Hsia Chen, Eric H Bernicker, Jenny C Chang
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta, Luz A Venta, Mary R Schwartz, Wei Qian, Yitian Xu, Licheng Zhang, John Kuhn, Tejal Patel, Angel A Rodriguez, Anna Belcheva, Jorge G Darcourt, Joe E Ensor, Eric H Bernicker, Ping-Ying Pan, Shu-Hsia Chen, Delphine J Lee, Polly A Niravath, Jenny C Chang
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer. Science translational medicine 13 (624) (2021)
Ethan Burns, Emre Koca, Jiaqiong Xu, Edward McLean, Rosetta Lee, Tejal Patel, Jenny Chang, Polly A Niravath
Measuring Ovarian Escape in Premenopausal Estrogen Receptor-Positive Breast Cancer Patients on Ovarian Suppression Therapy. The oncologist 26 (6) (2021)